David Shaw’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-1,600
Closed -$1.02M 4777
2025
Q3
$1.02M Buy
+1,600
New +$971K ﹤0.01% 3437
2025
Q2
Sell
-5,100
Closed -$2.14M 4501
2025
Q1
$2.14M Sell
5,100
-3,900
-43% -$1.69M ﹤0.01% 2556
2024
Q4
$3.72M Buy
9,000
+4,900
+120% +$2.15M ﹤0.01% 2226
2024
Q3
$2.07M Buy
4,100
+3,000
+273% +$1.46M ﹤0.01% 2690
2024
Q2
$536K Buy
+1,100
New +$552K ﹤0.01% 3583
2022
Q4
Sell
-14,000
Closed -$4.56M 4968
2022
Q3
$4.56M Buy
14,000
+4,000
+40% +$1.47M 0.01% 2202
2022
Q2
$3.51M Sell
10,000
-10,900
-52% -$4.44M ﹤0.01% 2559
2022
Q1
$11.4M Buy
+20,900
New +$11M 0.01% 1484
2021
Q4
Sell
-10,000
Closed -$6.22M 5533
2021
Q3
$6.22M Buy
+10,000
New +$6.72M 0.01% 1901
2018
Q4
Sell
-5,000
Closed -$1.25M 3863
2018
Q3
$1.25M Buy
+5,000
New +$1.21M ﹤0.01% 2537
2014
Q1
Sell
-20,000
Closed -$1.06M 4434
2013
Q4
$1.06M Hold
20,000
﹤0.01% 3118
2013
Q3
$997K Hold
20,000
﹤0.01% 3042
2013
Q2
$898K Buy
+20,000
New +$874K ﹤0.01% 2806

Other funds holding IDXX

David Shaw's IDXX Position: Q2 2026 in Review

David Shaw sold out of Idexx Laboratories (IDXX) in Q2 2026, closing a stake of 1,074 shares — an estimated $603K sold.

David Shaw first reported a position in IDXX in Q2 2013 and held it in 41 quarters. The position peaked at $100M in Q1 2025. 1,293 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • David Shaw reported no remaining Idexx Laboratories position as of Q2 2026 after selling out during the quarter.
  • David Shaw sold 1,074 Idexx Laboratories shares in Q2 2026, an estimated $603K.
  • David Shaw first reported a position in Idexx Laboratories in Q2 2013 and held it in 41 quarters.
  • David Shaw's Idexx Laboratories position peaked at $100M in Q1 2025.
  • 1,293 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.